Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1021/acsptsci.0c00027 http://scihub22266oqcxt.onion/10.1021/acsptsci.0c00027 C7233852!7233852!32551433     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       ACS+Pharmacol+Transl+Sci 2020 ; 3 (3): 401-17 Nephropedia Template TP {{tp|p=32551433|t=2020. Rapid and Point-of-Care Testing in Respiratory Tract Infections: An Antibiotic Guardian?|pdf=|usr=}}{{32551433}} gab.com Text Rapid and Point-of-Care Testing in Respiratory Tract Infections: An Antibiotic Guardian JO: ACS Pharmacol Transl Sci http://www.kidney.de/pget.php?&tw=1&pmid=32551433 #FOAvip This is a narrative review on the potential of rapid and point-of-care microbiological testing in pneumonia patients, focusing particularly on hospital-acquired and ventilator-associated pneumonia, which have substantial mortality and diverse microbiology. This work is written from a United Kingdom perspective, but much of it is generalizable internationally. In a world where antimicrobial resistance is a major international threat, the use of rapid molecular diagnostics has great potential to improve both the management of pneumonia patients and the stewardship of antibiotics. Rapid tests potentially can distinguish patients with bacterial versus viral infection and can swiftly identify bacterial pathogens and their resistances. We seek to answer the question: ?Can such tests be used as an antibiotic guardian?? Their availability at the bedside rather than in the laboratory should best ensure that results are swiftly used to optimize patient management but will raise new challenges, not the least with respect to maintaining quality control and microbiology/infection control input. A further challenge lies in assessing the degree of trust that treating clinicians will place in these molecular diagnostic tests, particularly when early de-escalation of antibiotic therapy is indicated. Twit Text FOAVip Rapid and Point-of-Care Testing in Respiratory Tract Infections: An Antibiotic Guardian ????ACS Pharmacol Transl Sci http://www.kidney.de/pget.php?&tw=1&pmid=32551433 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32551433 #FOAvip English Wikipedia <ref>{{Cite pmid|32551433}}</ref> Rapid and Point-of-Care Testing in Respiratory Tract Infections: An Antibiotic Guardian? #MMPMID32551433 Dhesi Z; Enne VI; O?Grady J; Gant V; Livermore DM ACS Pharmacol Transl Sci 2020[Jun]; 3 (3): 401-17 PMID32551433show ga This is a narrative review on the potential of rapid and point-of-care microbiological testing in pneumonia patients, focusing particularly on hospital-acquired and ventilator-associated pneumonia, which have substantial mortality and diverse microbiology. This work is written from a United Kingdom perspective, but much of it is generalizable internationally. In a world where antimicrobial resistance is a major international threat, the use of rapid molecular diagnostics has great potential to improve both the management of pneumonia patients and the stewardship of antibiotics. Rapid tests potentially can distinguish patients with bacterial versus viral infection and can swiftly identify bacterial pathogens and their resistances. We seek to answer the question: ?Can such tests be used as an antibiotic guardian?? Their availability at the bedside rather than in the laboratory should best ensure that results are swiftly used to optimize patient management but will raise new challenges, not the least with respect to maintaining quality control and microbiology/infection control input. A further challenge lies in assessing the degree of trust that treating clinicians will place in these molecular diagnostic tests, particularly when early de-escalation of antibiotic therapy is indicated. äRapid and Point-of-Care Testing in Respiratory Tract Infections: An An(epmc).pdf DeepDyve Pubget Overpricing